Source: Annual Congress 2009 - Biomarkers and biology in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Maclay, D. McAllister, N. Mills, D. Newby, W. MacNee (Edinburgh, United Kingdom). Platelet activation is enhanced in stable and exacerbated COPD. Eur Respir J 2009; 34: Suppl. 53, 426

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbations of COPD induce a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Platelet indices as inflammatory markers in stable COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Platelet depletion abolishes neutrophil recruitment in non-allergic murine models of acute inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 760s Year: 2006 Platelet activation correlates with disease severity in bronchiectasis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Neutrophil activation in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 400s Year: 2003 Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum Source: Annual Congress 2004 - Role of infection in COPD Year: 2004 Increased apoptosis in induced sputum cells in stable COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 The role of complement activation in COPD exacerbation recovery Source: ERJ Open Res, 2 (4) 00027-2016; 10.1183/23120541.00027-2016 Year: 2016 Respiratory syncytial-virus induced cytokine production from leukocytes is impaired in severe asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Altered platelet function in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Stability of the eosinophilic phenotype in stable and exacerbated COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 Decreased toll-like receptor 4 expression in induced sputum associated with increased frequency of acute exacerbation in COPD patients Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Basal membrane biomarkers in stable and exacerbated COPD Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Platelet aggregation status in chronic obstructive pulmonary disease associated with SARS-Cov-19 Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Cilomilast decreases exacerbations and maintains lung function in patients with poorly reversible COPD Source: Eur Respir J 2004; 24: Suppl. 48, 88s Year: 2004 Redox systems of neutrophils of patients with exacerbated COPD Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 Lung inflammation is significantly reduced by recovery of neutrophil apoptosis in vivo Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD Year: 2012 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010